Common use of Buyer Preamble Clause in Contracts

Buyer Preamble. Buyer Ancillary Agreements 4.2 Buyer Indemnitees 8.1(a) Cap 8.1(a) Closing 1.2 Closing Date 1.2 Company Recitals Company Software 3.18(g) Confidentiality Agreement 10.8 Developed Intellectual Property 3.18(d) ERISA Affiliate 3.14(b) Estimated Closing Statement 2.1 Estimated Indebtedness 2.1 Estimated Net Working Capital 2.1 Estimated Purchase Price 2.2 FCPA 3.22 Final Indebtedness 2.3(d) Final Net Working Capital 2.3(d) Financial Statements 3.7 Fundamental Representations 6.2(a) Indemnified Party 8.2(a) Indemnifying Party 8.2(a) Insurance Policies 3.17 IP Agreement 6.2(d)(v) Liabilities 3.8 Linear Supply Agreement 9.1(a) Losses 8.1(a) Material Contract 3.13(a) Parent Indebtedness 5.14 Post-Closing Covenants 8.1(b) Pre-Closing Products 8.1(a)(iv) Proposed Final Closing Statement 2.3(a) Proposed Final Indebtedness 2.3(a) Proposed Final Net Working Capital 2.3(a) Purchase Price 2.3(d) Release Agreement 6.2(d)(iii) Release Letters 5.14 Sale 1.1 Seller Preamble Seller Ancillary Agreements 3.3

Buyer Preamble. Buyer Ancillary Agreements 4.2 Common Stock Recitals Buyer Competing Business 5.24(c) Buyer Disclosure Schedules Article IV Buyer Incentive Plans 4.7(b) Buyer Indemnitees 8.1(a8.2 Buyer SEC Documents 4.6(a) Cap 8.1(a8.4(b) Claim 8.5(a) Claim Notice 8.5(a) Closing 1.2 2.3(a) Closing Cash 2.5(a) Closing Date 1.2 2.3(a) Closing Indebtedness 2.5(a) Closing Net Working Capital 2.5(a) Closing Transaction Expenses 2.5(a) Companies Recitals Definition Location Company Recitals Company Software 3.18(g) Confidentiality Agreement 10.8 Developed Intellectual Property 3.18(d5.6(a) ERISA Affiliate 3.14(bConsents 5.7(a) Contaminant 3.15(h) Direct Claim 8.5(a) Effect 1.1 Environmental Laws 3.18(d)(i) Environmental Permits 3.18(d)(ii) Estimated Closing Statement 2.1 Cash 2.4 Estimated Indebtedness 2.1 2.4 Estimated Net Working Capital 2.1 2.4 Estimated Purchase Price 2.2 FCPA 3.22 Final Indebtedness 2.3(dTransaction Expenses 2.4 Exchange Act 4.6(a) Final Net Working Capital 2.3(dClosing Statement 2.5(a) Financial Statements 3.7 Fundamental Representations 6.2(aForm S-3 5.13(a) Xxxxxx Xxxx 9.19(a) Hazardous Materials 3.18(d)(iii) HSR Act 1.1 Indemnification Threshold 8.4(a) Indemnified Party 8.2(a8.5(a) Indemnifying Party 8.2(a8.5(a) Insurance Policies 3.17 IP Agreement 6.2(d)(vIndependent Accounting Firm 2.5(c) Liabilities 3.8 Linear Supply Agreement 9.1(a) Losses 8.1(a) Material Contract 3.13(a) Parent Indebtedness 5.14 Post-Closing Covenants 8.1(b) Pre-Closing Products 8.1(a)(iv) Proposed Final Closing Statement 2.3(a) Proposed Final Indebtedness 2.3(a) Proposed Final Net Working Capital 2.3(a) Purchase Price 2.3(d) Release Agreement 6.2(d)(iii) Release Letters 5.14 Sale 1.1 Seller Preamble Seller Ancillary Agreements 3.3Interests Recitals

Buyer Preamble. Buyer Ancillary Agreements 4.2 Buyer Indemnitees 8.1(a8.2 Cancelled Shares 2.7(d) Cap 8.1(aCERCLA 3.16(b)(ii) Certificate of Merger 2.2(b) Certificates 2.10(b) Claim Notice 8.4(a) Class B Common Stock Recitals Closing 2.2(a) Closing 1.2 Balance Sheet 2.13(a) Closing Cash 2.13(a) Closing Date 1.2 Company 2.2(a) Closing Indebtedness 2.13(a) Closing Net Working Capital 2.13(a) Closing Transaction Expenses 2.13(a) Code 3.10(b) Common Stock Purchase Recitals Company Software 3.18(gPreamble Company 401(k) Plan 5.11 Company Owned IP 3.14(a) Confidentiality Agreement 10.8 Developed Intellectual Property 3.18(d5.7 Cooley 10.19 Current D&O Policy 5.6(a) D&O Indemnified Parties 5.6(b) Debt Payoff Letter 7.3(h) DGCL Recitals Direct Claim 8.4(c) Disclosure Schedules Article III Dissenting Shares 2.8 Effective Time 2.2(b) Employee Options 6.8(c) Environmental Law 3.16(b)(i) ERISA Affiliate 3.14(b3.10(a)(i) Estimated Closing Statement 2.1 Cash 2.12 Estimated Indebtedness 2.1 2.12 Estimated Net Working Capital 2.1 2.12 Estimated Purchase Price 2.2 FCPA 3.22 Transaction Expenses 2.12 Final Indebtedness 2.3(dCash Merger Consideration 2.13(f) Final Net Working Capital 2.3(d) Financial Statements 3.7 Fundamental Representations 6.2(a) Indemnified Party 8.2(a) Indemnifying Party 8.2(a) Insurance Policies 3.17 IP Agreement 6.2(d)(v) Liabilities 3.8 Linear Supply Agreement 9.1(a) Losses 8.1(a) Material Contract 3.13(a) Parent Indebtedness 5.14 Post-Closing Covenants 8.1(b) Pre-Closing Products 8.1(a)(iv) Proposed Final Closing Statement 2.3(a) Proposed Final Indebtedness 2.3(a) Proposed Final Net Working Capital 2.3(a) Purchase Price 2.3(d) Release Agreement 6.2(d)(iii) Release Letters 5.14 Sale 1.1 Seller Preamble Seller Ancillary Agreements 3.32.13(a)

Buyer Preamble. Buyer Ancillary Agreements 4.2 Benefit Plans 6.16(a) Buyer Indemnitees 8.1(aFundamental Representations 8.2(a) Buyer’s Notice of Disagreement 2.3 Cap 8.1(aAmount 6.13(d) CERCLA 4.16(f)(iii) Claim Notice 9.4(a) Closing 1.2 2.2(a) Closing Balance Sheet 2.4(a) Closing Cash 2.4(a) Closing Date 1.2 2.2(a) Closing Indebtedness 2.4(a) Closing Net Working Capital 2.4(a) Closing Transaction Expenses 2.4(a) Company Recitals Preamble Definition Location Company Software 3.18(gFundamental Representations 8.3(a) Company Registered IP 4.14(e) Confidential Information 6.7(b) Confidentiality Agreement 10.8 Developed Intellectual Property 3.18(d6.7(a) Continuing Employee 6.16(a) Current Representation 11.19(b) Debt Payoff Letter 2.2(d) Deductible 9.5 Designated Person 11.19(b) Direct Claim 9.4(d) Directors 6.12 Disclosure Schedules Article III Environmental Laws 4.16(f)(i) Environmental Permits 4.16(f)(ii) ERISA Affiliate 3.14(b4.10(a)(i) Estimated Closing Statement 2.1 Cash 2.3 Estimated Indebtedness 2.1 2.3 Estimated Net Working Capital 2.1 2.3 Estimated Purchase Price 2.2 FCPA 3.22 Final Indebtedness 2.3(dTransaction Expenses 2.3 Export Approvals 4.24(b)(i) Final Net Working Capital 2.3(dClosing Statement 2.4(a) Financial Statements 3.7 Fundamental Representations 6.2(a4.6(a) Fractional Share Cash Amount 2.2(c) Hazardous Substances 4.16(f)(iii) HSR Act 3.3(b) Incentive Units 2.1 Indemnified Party 8.2(a9.4(a) Indemnifying Party 8.2(a9.4(a) Insurance Policies 3.17 IP Agreement 6.2(d)(vIndependent Accounting Firm 2.4(c) Liabilities 3.8 Linear Supply Agreement 9.1(aInterim Financial Statements 4.6(a) IRS 4.10(b) Key Employees Recitals Key Employment Agreements Recitals Losses 8.1(a9.2 Material Contracts 4.17(a) Material Contract 3.13(aMultiemployer Plan 4.10(c) Parent Multiple Employer Plan 4.10(c) NASDAQ 42 Net Adjustment Amount 2.4(f)(i) Notice of Disagreement 2.4(b) Payoff Indebtedness 5.14 2.2(b)(iii) Permits 4.8(b) Permitted Encumbrances 4.12(a) Personally Identifiable Information 4.20(b) Post-Closing Covenants 8.1(bRepresentation 11.19(b) Definition Location Pre-Closing Products 8.1(a)(iv) Proposed Final Claims 6.5 Pre-Closing Matters 6.5 Pre-Closing Period 7.1 Preliminary Closing Balance Sheet 2.3 Preliminary Closing Statement 2.3(a) Proposed Final Indebtedness 2.3(a) Proposed Final Net Working Capital 2.3(a2.3 Privileged Communications 11.19(c) Purchase Price 2.3(dAllocation Schedule 2.5 Purchaser SEC Filings 5.8 Release 4.16(f)(iv) Release Agreement 6.2(d)(iiiReleased Parties 6.5 Remediation 4.16(f)(v) Release Letters 5.14 Sale 1.1 Securities Act 3.5 Seller Preamble Seller Ancillary Agreements 3.3Fundamental Representations 8.3(a) Sellers Preamble Sellers Representative Preamble Sellers’ Allocation Schedule 2.2(f) Straddle Period 7.1 Tax Allocation Purchase Price 2.5 Tax Proceeding 7.2 Third Party Claim 9.4(a) Transaction Expenses Payoff Instructions 2.2(e) Units Recitals WARN Obligation 6.16(c)

Buyer Preamble. Buyer Ancillary Agreements 4.2 Plan 5.1(b) Buyer Indemnitees 8.1(a) Cap 8.1(aRepresentatives 4.9 Closing 2.2(a) Closing 1.2 Balance Sheet 2.3(b)(i) Closing Date 1.2 2.2(a) Closing Statement 2.3(b)(i) Company Preamble Company Securities Recitals Company Software 3.18(g) Confidentiality Agreement 10.8 Developed Intellectual Property 3.18(d5.2 Contribution Recitals Conversion Recitals Covered Matter 7.10 Disclosure Schedule Article III Dispute Notice 2.3(b)(ii) ERISA Affiliate 3.14(bDisputed Item 2.3(b)(ii) DFARS 3.28(x) Effective Time 2.2(a) Environmental Permits 3.17(a) Escrow Account 2.2(b)(ii)(B) Escrow Agent 2.2(b)(ii)(B) Escrow Agreement 2.2(b)(ii)(B) Estimated Closing Balance Sheet 2.3(a) Estimated Closing Statement 2.1 Estimated Indebtedness 2.1 Estimated Net Working Capital 2.1 2.3(a) Estimated Purchase Price 2.2 FCPA 3.22 Final Indebtedness 2.3(d2.3(a) Final Net Working Capital 2.3(dFARS 3.28(x) Financial Statements 3.7 Fundamental Representations 6.2(a3.6 Independent Accountant 2.3(b)(ii) Indemnified Party 8.2(aLatest Balance Sheet 3.6 Term Section New LLC Recitals NISPOM 3.28(x) Indemnifying Party 8.2(a) Insurance Policies 3.17 IP Agreement 6.2(d)(v) Liabilities 3.8 Linear Supply Agreement 9.1(a) Losses 8.1(aOCI 3.28(x) Material Contract 3.13(aContracts 3.12(a) Parent Indebtedness 5.14 Post-Closing Covenants 8.1(b) Pre-Closing Products 8.1(a)(iv) Proposed Final Closing Statement 2.3(a) Proposed Final Indebtedness 2.3(a) Proposed Final Net Working Capital 2.3(a) Representation 7.15 Purchase Price 2.3(d2.1 PWC 1.1 Real Property Leases 3.10 Released Parties 7.16 Releasing Parties 7.16 Relevant Persons 3.16(b) Release Agreement 6.2(d)(iiiResolution Period 2.3(b)(ii) Release Letters 5.14 Sale 1.1 Seller Preamble Group 7.15 Seller Ancillary Agreements 3.3Prepared Returns 5.4(a)(i) Sellers’ Representatives 3.27 Solvent 4.7 Tax Allocation Schedule Methodology 5.4(g)(ii) Tax Claim 5.4(e) Transfer Taxes 5.4(d) Unresolved Items 2.3(b)(ii) Waiving Parties 7.15 WARN 5.1(d)

Buyer Preamble. Buyer Ancillary Agreements 4.2 Fundamental Representations 10.1(a)(i) Buyer Indemnitees 8.1(a10.2 Buyer Intermediate Inventory 6.9A Cap 10.4(b) Cap 8.1(aTerm Section Cidara CMO 6.9A Cidara CMO Agreement 6.9A CLA/CSA Novation Agreement 3.2(a)(i) Claim 10.5(a) Claim Notice 10.5(a) Closing 1.2 3.1 Closing Date 1.2 Company Recitals Company Software 3.18(g3.1 Comparator Drug and Placebo Clinical Supplies Schedule 2.1(h) Competitive Activity 6.5(a) Confidential Information 6.4(c) Confidentiality Agreement 10.8 Developed Intellectual Property 3.18(d6.4(d) ERISA Affiliate 3.14(bConveyance Taxes 7.4 Covenant 10.1(a)(iv) Estimated Closing Statement 2.1 Estimated Indebtedness 2.1 Estimated Net Working Capital 2.1 Estimated Purchase Price 2.2 FCPA 3.22 Final Indebtedness 2.3(dData Room 5.8 De Minimis Threshold 10.4(a)(i) Final Net Working Capital 2.3(dDeductible 10.4(a)(ii) Deferred Assigned Contracts 2.6(a) Deferred Assigned Contract Transfer Date 2.6(b) Direct Claim 10.5(a) Disclosure Schedules Article 4 Disparaging Remarks 6.5(c) Domain Name Transfer Agreement 3.2(a)(v) Effective Time 3.1 Excluded Liabilities 2.4 Excluded Taxes 2.4(d) Exclusivity Period 6.5(a) Existing Stock 9.1(b) Financial Statements 3.7 Fundamental Representations 6.2(a4.5(a) ICON 3.3 Indemnified Party 8.2(a10.5(a) Indemnifying Party 8.2(a10.5(a) Insurance Policies 3.17 Intellectual Property Assignment Agreement 3.2(a)(iv) Intermediate 6.9A IP Agreement 6.2(d)(vLicense 4.7(a)(xi) Liabilities 3.8 Linear Supply Agreement 9.1(a) Losses 8.1(aLicensees 9.1(c) Material Contract 3.13(aContracts 4.7(a) Parent Indebtedness 5.14 Post-Closing Covenants 8.1(b) Pre-Closing Products 8.1(a)(iv) Proposed Final Closing Statement 2.3(a) Proposed Final Indebtedness 2.3(a) Proposed Final Net Working Capital 2.3(a) Purchase Price 2.3(d) Release Agreement 6.2(d)(iii) Release Letters 5.14 Sale 1.1 Seller Preamble Seller Ancillary Agreements 3.3Material Permit 4.9(c)